Ganglionic blocker: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Ganglionic blocker": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
Latest revision as of 15:26, 9 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A ganglionic blocker is a type of medication which inhibits postganglionic transmission, primariliy by acting as a nicotinic antagonist, for example hexamethonium, pentolinium, mecamylamine, trimetaphan and pempidine.
Ganglionic blockers are used less frequently now than they were in the past, because more selective agents are now available. However, they are still used in some emergency situations, such as aortic dissection.
External links
- Ganglionic+blockers at the US National Library of Medicine Medical Subject Headings (MeSH)